losartan actavis
actavis group ptc ehf. - losartano kalio druska - plėvele dengtos tabletės - 100 mg; 50 mg; 25 mg; 12,5 mg - losartan
losartan hydrochlorothiazide actavis
actavis group ptc ehf. - losartanas/hidrochlorotiazidas - plėvele dengtos tabletės - 50 mg/12,5 mg; 100 mg/25 mg - losartan and diuretics
abiraterone accord
accord healthcare s.l.u. - abiraterono acetatas - prostatos navikai - endokrininė terapija - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone g.l. pharma
g.l. pharma gmbh - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone
abiraterone richter
gedeon richter plc - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone
abiraterone sandoz
sandoz d.d. - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone
tatica
egis pharmaceuticals plc - abiraterono acetatas - plėvele dengtos tabletės - 250 mg - abiraterone
tatica
egis pharmaceuticals plc - abiraterono acetatas - plėvele dengtos tabletės - 500 mg - abiraterone
abiraterone mylan
mylan ireland limited - abiraterono acetatas - prostatos navikai - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.
abiraterone sandoz [abiraterone ebewe]
sandoz d.d. - abiraterono acetatas - plėvele dengtos tabletės - 1000 mg - abiraterone